Body composition and quality of life in adults treated with GH therapy: A systematic review and meta-analysis

Ahmad Hazem, Mohamed B. Elamin, Irina Bancos, German Malaga, Gabriela Prutsky, Juan Pablo Domecq, Tarig A. Elraiyah, Nisrin O. Abu Elnour, Yolanda Prevost, Jaime PAlmandoz, Claudia Zeballos-Palacios, Edgar R. Velasquez, Patricia J. Erwin, Neena Natt, Victor M. Montori, Mohammad Hassan Murad

Research output: Contribution to journalReview article

53 Scopus citations

Abstract

Objective: To summarise the evidence about the efficacy and safety of using GH in adults with GH deficiency focusing on quality of life and body composition. Data sources: We searched MEDLINE, EMBASE, Cochrane CENTRAL, Web of Science and Scopus throughApril 2011.We also reviewed reference lists and contacted experts to identify candidate studies. Study selection:Reviewers, working independently and in duplicate, selected randomised controlled trials (RCTs) that compared GH to placebo. Data synthesis: We pooled the relative risk (RR) and weighted mean difference (WMD) by the random effects model and assessed heterogeneity using the I 2 statistic. Results: Fifty-four RCTswere included enrolling over 3400 patients. The quality of the included trialswas fair. GH use was associated with statistically significant reduction in weight (WMD, 95% confidence interval (95% CI): K2.31 kg, K2.66 and K1.96) and body fat content (WMD, 95% CI: K2.56 kg, K2.97 andK2.16); increase in lean body mass(WMD,95%CI: 1.38, 1.10 and 1.65), the risk of oedema (RR, 95% CI: 6.07, 4.34 and 8.48) and joint stiffness (RR, 95% CI: 4.17, 1.4 and 12.38); without significant changes in body mass index, bone mineral density or other adverse effects. Quality of life measures improved in 11 of the 16 trials although meta-analysis was not feasible. Results: GH therapy in adults with confirmed GH deficiency reduces weight and body fat, increases lean body mass and increases oedema and joint stiffness. Most trials demonstrated improvement in quality of life measures.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalEuropean journal of endocrinology
Volume166
Issue number1
DOIs
StatePublished - Jan 1 2012

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Body composition and quality of life in adults treated with GH therapy: A systematic review and meta-analysis'. Together they form a unique fingerprint.

  • Cite this

    Hazem, A., Elamin, M. B., Bancos, I., Malaga, G., Prutsky, G., Domecq, J. P., Elraiyah, T. A., Abu Elnour, N. O., Prevost, Y., PAlmandoz, J., Zeballos-Palacios, C., Velasquez, E. R., Erwin, P. J., Natt, N., Montori, V. M., & Murad, M. H. (2012). Body composition and quality of life in adults treated with GH therapy: A systematic review and meta-analysis. European journal of endocrinology, 166(1), 13-20. https://doi.org/10.1530/EJE-11-0558